You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SCLC small cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Molecular Analysis and Treatment Options of SCLC

Recruiting
  • Small-cell Lung Cancer
  • +4 more
  • Shanghai, China
    Shanghai Chest Hospital
Jul 6, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer (LS-SCLC)
  • Tifcemalimab injection
  • +3 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital & Institute
Oct 18, 2023

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

Recruiting
  • SCLC,Extensive Stage
  • PD-(L)1 antibody immunotherapy
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Jul 3, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • quaratusugene ozeplasmid
  • atezolizumab
  • (no location specified)
Jan 19, 2023

Small Cell Lung Cancer Trial (SC0245, Irinotecan)

Not yet recruiting
  • Small Cell Lung Cancer
  • (no location specified)
Feb 7, 2023

Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer Trial in Nashville (drug, biological, radiation, procedure)

Not yet recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Stage IV Lung Cancer
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Oct 25, 2023

Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

Recruiting
  • Extensive Small Cell Lung Cancer
  • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
  • Jinan, Shan Dong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

Recruiting
  • EGFR-Mutated Non-Small-Cell Lung Carcinoma
  • Small Cell/Neuroendocrine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

Recruiting
  • Small Cell Lung Cancer
  • AL8326 low dose group
  • +2 more
  • Saint Louis, Missouri
    Siteman cancer center, Washington University
Nov 1, 2022

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Jinan, China
  • +2 more
Sep 10, 2023

Outcomes ofBrazilian Cohort of Previously Untreated Extensive

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Observational study
  • (no location specified)
Aug 24, 2023

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Nomogram Predicting Survival in Chinese SCLC Patients

Completed
  • Small Cell Lung Cancer
  • initial chemotherapy response
  • (no location specified)
Jan 8, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • (no location specified)
Aug 7, 2023

Small Cell Lung Cancer Extensive Stage Trial (Pembrolizumab, Plinabulin plus Etoposide and Platinum)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Pembrolizumab, Plinabulin plus Etoposide and Platinum
  • (no location specified)
Feb 15, 2023

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • BI 764532
  • [89Zr]Zr-BI 764532
  • (no location specified)
Jul 31, 2023

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

Completed
  • Small Cell Lung Cancer
  • atezolizumab
  • Chalon-sur-Saône, France
  • +1 more
Jan 5, 2023

Small Cell Lung Cancer (SCLC) Trial in Guangzhou (Anlotinib Tislelizumab Irinotecan)

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • Anlotinib Tislelizumab Irinotecan
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Traditional Chinese Medicine
Jun 30, 2022

Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Durvalumab 50 MG/1 ML Intravenous Solution
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 31, 2022